StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
BofA Securities Moves GlaxoSmithKline (GSK) at Underperform
December 5, 2022 5:47 AM
(Updated - December 5, 2022 5:55 AM EST)
BofA Securities analyst Graham Perry downgrades GlaxoSmithKline (NYSE: GSK) Underperform rating ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Downgrades
Next Articles
BofA Securities Moves GlaxoSmithKline (GSK:LN) (GSK) at Underperform
December 5, 2022 5:47 AM
Form 6-K GSK PLC For: Dec 02
December 2, 2022 11:40 AM
Form 6-K GSK PLC For: Dec 02
December 2, 2022 6:55 AM
Form 6-K GSK PLC For: Dec 02
December 2, 2022 6:43 AM
GlaxoSmithKline (GSK:LN) (GSK) PT Lowered to GBP15.50 at Citi
December 2, 2022 4:08 AM
Form 6-K GSK PLC For: Dec 01
December 1, 2022 12:20 PM
Major Corporations Launch New Coalition to Help End HIV in the United States
December 1, 2022 8:00 AM